Tag

HIV/AIDS Policy

Governor’s 9C Cuts Could Impact Access to Healthcare

By | Fenway Health Newsroom, HIV/AIDS | No Comments
Massachusetts Governor Charlie Baker this week announced $98 million in budget cuts in response to anticipated revenue shortfalls, including nearly $1 million in cuts to the HIV/AIDS line item. These cuts will impact a range of programs, including HIV counseling and testing, access to pre-exposure prophylaxis (PrEP), and access to clean syringes and life-saving Narcan. “These reductions are concerning and could threaten the care and services that Fenway Health and other organizations provide to thousands of people living with HIV/AIDS and hepatitis C, as well as the prevention programs that have been so effective in helping us reduce new diagnoses 
Read More

Massachusetts Getting to Zero Coalition releases plan to eliminate HIV/AIDS in Massachusetts

By | AIDS Action Committee, AIDS Advocacy, Fenway Health Newsroom, HIV/AIDS | No Comments
The Massachusetts Getting to Zero Coalition, led by the AIDS Action Committee and Fenway Health, and over 35 supporting organizations from the six health regions of the Commonwealth, today released a plan to end HIV/AIDS in Massachusetts. The plan seeks to ensure that by 2020, 90 percent of those living with HIV are aware of their status; 90 percent of those diagnosed with HIV are treated with antiretroviral therapy; and 90 percent of those receiving antiretroviral treatment are virally suppressed. It is modeled on the Getting to Zero new HIV infections plan created by the Joint United Nations Programme on 
Read More

Treatment for Lipodystrophy: What you need to know about insurance coverage for treatment of HIV-associated lipodystrophy

By | AIDS Action Committee, AIDS Advocacy, Fenway Health Newsroom, HIV/AIDS, Living with HIV/AIDS | No Comments
Note: The following was written by GLAD in regards to the great work of the Treat Lipodystrophy Coalition. On August 10, Governor Charlie Baker signed into law An Act Relative to HIV-Associated Lipodystrophy Syndrome Treatment, and the law will go into effect November 9. This first-of-its-kind legislation, sponsored by Senator Mark Montigny and Representative Sarah Peake, requires public and private insurers to cover treatment of a debilitating side effect of early HIV medications. This law means that some of the longest-term survivors of the HIV epidemic will finally have access to critical health care they need and deserve. The information 
Read More

The Fenway Institute Represents at AIDS 2016 in Durban, South Africa

By | Fenway News, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Digital technologies. Social networks. Breakthroughs in habit formation. Advances in medical therapy. These are some of the innovative tools that scientists and researchers at The Fenway Institute are exploring to fight the HIV pandemic here at home and around the world. Next week, a team of five Fenway scientists and researchers led by Kenneth H. Mayer, M.D., Medical Research Director and Co-Chair of The Fenway Institute, will bring their latest findings to the International AIDS Conference in Durban, South Africa. The annual event features experts in science, public policy, and public health presenting new research in HIV treatment, prevention, and 
Read More

Fenway’s Dr. Kenneth Mayer Receives HPTN’s Ward Cates Spirit Award

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
We are thrilled to announce that Kenneth Mayer, MD, Co-Chair and Medical Research Director at The Fenway Institute, has been honored by the HIV Prevention Trials Network (HPTN) with its first ever Ward Cates Spirit Award. This award recognizes a Network member who has made outstanding contributions to HPTN’s mission through public health advocacy, leadership, and mentoring. The Spirit Award is named for Willard (Ward) Cates Jr., MD, MPH, Distinguished Scientist and President Emeritus of FHI 360 and Principal Investigator of HIVNET’s International Master Contractor and HPTN from 1994 to 2006. Cates passed away in March of 2016. Winners of 
Read More